Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study)

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 10, 2019

Primary Completion Date

July 24, 2019

Study Completion Date

July 24, 2019

Conditions
Healthy Adult Subjects
Interventions
DRUG

MT-1186

A crossover study in which Japanese healthy subjects receive a single dose of MT-1186 under several dosing condition on Day 1, 3, 5, 7 and 24 according to their treatment sequence.

Trial Locations (1)

Unknown

Investigational site, Tokyo

All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY